The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Helix BioPharma Corp. - Immuno-Oncology Company Focused on Cancer Therapy Discusses Competitive Advantages and Growth Drivers for 2019-2020

SNNLive spoke with Heman Chao, PhD, Managing Partner of Helix BioPharma Corp. (TSX: HBP), at RHK Capital's 2019 Disruptive Growth and Healthcare Conference in New York, NY.

Share With

Monday, October 07, 2019

   

© 2019 Stock News Now